Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-21-021366
Filing Date
2021-04-28
Accepted
2021-04-28 16:16:09
Documents
25
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A apvo-10ka_20201231.htm 10-K/A 1144894
2 EX-31.3 apvo-ex313_177.htm EX-31.3 3267
3 EX-31.4 apvo-ex314_176.htm EX-31.4 3488
4 GRAPHIC g3igduewuqt1000010.jpg GRAPHIC 1413
5 GRAPHIC g3igduewuqt1000002.jpg GRAPHIC 52211
6 GRAPHIC g3igduewuqt1000003.jpg GRAPHIC 1413
7 GRAPHIC g3igduewuqt1000006.jpg GRAPHIC 1413
8 GRAPHIC g3igduewuqt1000005.jpg GRAPHIC 1413
9 GRAPHIC g3igduewuqt1000008.jpg GRAPHIC 1413
10 GRAPHIC g3igduewuqt1000009.jpg GRAPHIC 1656
11 GRAPHIC g3igduewuqt1000012.jpg GRAPHIC 1413
12 GRAPHIC g3igduewuqt1000001.jpg GRAPHIC 58092
13 GRAPHIC g3igduewuqt1000011.jpg GRAPHIC 1413
14 GRAPHIC g3igduewuqt1000007.jpg GRAPHIC 1413
15 GRAPHIC g3igduewuqt1000004.jpg GRAPHIC 1413
  Complete submission text file 0001564590-21-021366.txt   1489069

Data Files

Seq Description Document Type Size
16 XBRL INSTANCE DOCUMENT apvo-20201231.xml EX-101.INS 10120
17 XBRL TAXONOMY EXTENSION SCHEMA apvo-20201231.xsd EX-101.SCH 5816
18 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20201231_lab.xml EX-101.LAB 30018
19 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20201231_pre.xml EX-101.PRE 18039
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37746 | Film No.: 21864434
SIC: 2834 Pharmaceutical Preparations